Published by: Aaron Brown, Sr. Manager, Market Intelligence Insights Since the FDA and NIH signaled their pivot toward New Approach Methodologies (NAMs) early last year, the most meaningful developments have been in how quickly those signals have turned into practical pathways. FDA’s 2025 roadmap began allowing NAM‑supported INDs—initially for monoclonal antibodies—with options for streamlined review where […]
New survey insights reveal a measurable shift in how life science labs are responding to global financial uncertainty, rising operational costs, and upcoming U.S. tariff policies. Based on responses from more than 550 academic and industry researchers, the latest data from BioInformatics’ Beyond the Bench series captures how lab priorities, purchasing decisions, and funding strategies […]
This month marked the anniversary of the World Health Organization’s declaration of the SARS-CoV-2 outbreak as a pandemic. Virtually all aspects of normal life and business were quickly disrupted by the novel and deadly coronavirus as it spread across the world. But researchers and the analytical instrumentation companies that supply them rose to the occasion. […]
It’s an oft-told story that the fortune of Swedish chemist and businessman Alfred Nobel was founded on patented explosives, including dynamite. While his products were used beneficially in mining and construction applications, their wartime use in munitions gave him concern that he would be remembered solely as a ‘merchant of death’. Consequently, Nobel set aside […]
Politico reported today that CDC Director Robert Redfield said on Tuesday that he is not confident that U.S. labs have an adequate stock of the supplies used to extract genetic material from any virus in a patient’s sample — a critical step in coronavirus testing. The article goes on to quote Michael Mina, MD, PhD […]
The demand for pharmaceuticals grows higher each year, as the global population ages and diseases once associated with so-called developed regions, become more prominent in other areas. As medical knowledge elucidates the underlying causes and mechanisms of various diseases in fine detail, approaches to disease treatment are shifting. With the rise of precision medicine, medical […]
In vitro diagnostic testing costs little to the healthcare system and contributes much to clinical practice, which is part of the reason there is so much interest in the industry. It is a $69.2 billion-dollar market, with lots of players. A dozen large multi-test category players compete, hundreds of other concerns that may produce a […]
From when they first enter your website, to placing an order through a sales rep, to using technical support when setting up a new system — every time a scientist interacts with your company a branding opportunity presents itself. A dedicated customer experience program has a formal strategy to engage and satisfy, not merely serve. […]
Our colleagues at Kalorama Information have just published their latest report, The World Market for Biomarkers. Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease […]
The customer experience of a life science brand can begin before a customer makes a purchase or interact with a sales representative at a conference. Many different marketing materials could be the first touchpoint a customer has with your brand: catalogs and pamphlets sent to department mail boxes, downloadable product guides, or online ads about […]
